Insmed Inc
NASDAQ:INSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Insmed Inc
NASDAQ:INSM
|
US |
|
E
|
Eutelsat Communications SA
XMUN:E3B
|
FR |
|
Tata Technologies Ltd
NSE:TATATECH
|
IN |
|
Optiemus Infracom Ltd
NSE:OPTIEMUS
|
IN |
|
Spirit AeroSystems Holdings Inc
NYSE:SPR
|
US |
|
A
|
ams-OSRAM AG
VSE:AMS2
|
AT |
|
A
|
Advantest Corp
XMUN:VAN
|
JP |
|
dentalcorp Holdings Ltd
TSX:DNTL
|
CA |
|
M
|
Mulberry Group PLC
F:MUY
|
UK |
|
Mare Engineering Group SpA
F:EZ3
|
IT |
|
P
|
Proximus NV
LSE:0DPU
|
BE |
|
Bucher Industries AG
SIX:BUCN
|
CH |
|
Insurance Australia Group Ltd
ASX:IAG
|
AU |
|
Guanajuato Silver Company Ltd
XTSX:GSVR
|
CA |
|
D'Ieteren Group NV
F:DJD
|
BE |
|
B
|
Basf Se
BMV:BASN
|
DE |
|
G
|
Golden Arrow Merger Corp
NASDAQ:GAMC
|
US |
Wall St Price Targets
INSM Price Targets Summary
Insmed Inc
According to Wall Street analysts, the average 1-year price target for INSM is 201.82 USD with a low forecast of 141.4 USD and a high forecast of 255.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INSM's stock price target?
Price Target
201.82
USD
According to Wall Street analysts, the average 1-year price target for INSM is 201.82 USD with a low forecast of 141.4 USD and a high forecast of 255.15 USD.
What is the Revenue forecast for Insmed Inc?
Projected CAGR
43%
The compound annual growth rate for Revenue over the next 8 years is 43%.
What is the Gross Profit forecast for Insmed Inc?
Projected CAGR
45%
The compound annual growth rate for Gross Profit over the next 8 years is 45%.
